T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33106495.
- Also identified by DOI 10.1038/s41467-020-18961-0 and PMC identifier 7589501.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Mutations in nucleotide-binding oligomerization domain-containing protein 2 (NOD2) cause Blau syndrome, an inflammatory disorder characterized by uveitis. The antimicrobial functions of Nod2 are well-established, yet the cellular mechanisms by which dysregulated Nod2 causes uveitis remain unknown. Here, we report a non-conventional, T cell-intrinsic function for Nod2 in suppression of Th17 immunity and experimental uveitis. Reconstitution of lymphopenic hosts with Nod2<sup>-/-</sup> CD4<sup>+</sup> T cells or retina-specific autoreactive CD4<sup>+</sup> T cells lacking Nod2 reveals a T cell-autonomous, Rip2-independent mechanism for Nod2 in uveitis. In naive animals, Nod2 operates downstream of TCR ligation to suppress activation of memory CD4<sup>+</sup> T cells that associate with an autoreactive-like profile involving IL-17 and Ccr7. Interestingly, CD4<sup>+</sup> T cells from two Blau syndrome patients show elevated IL-17 and increased CCR7. Our data define Nod2 as a T cell-intrinsic rheostat of Th17 immunity, and open new avenues for T cell-based therapies for Nod2-associated disorders such as Blau syndrome.
Medical subject headings
- Nod2 Signaling Adaptor Protein
- Th17 Cells
- Uveitis